Summary
Background
A considerable amount of evidence collected from several experimental systems and clinical studies with nonsteroidal Anti-inflammatory drugs (NSAIDs) indicates that Cox-2 may play a major role in colorectal tumorigenesis, but little information about Cox-2 expression in pancreatic tumors is available. In this study, we investigated Cox-2 expression by means of both immunohistochemical analysis and immunoblot analysis in pancreatic tumors.
Methods
Fifty invasive ductal adenocarcinomas and 26 intraductal papillary-mucinous tumors (IPMTs) were used for immunohistochemical analysis, and five pancreatic cancer tissues and five pancreatic cancer cell lines for immunoblot analysis.
Results
Cox-2 was expressed in 72% of the invasive ductal adenocarcinomas, 31% of intraductal papillary-mucinous adenocarcinomas, and none of intraductal papillary-mucinous adenomas. The expression rate of Cox-2 in intraductal papillary-mucinous adenocarcinomas was significantly higher than that in intraductal papillary-mucinous adenomas, and that in invasive ductal adenocarcinomas was significantly higher than that in intraductal papillary-mucinous carcinomas. However, there was no significant correlation between Cox-2 expression and the prognosis and clinicopathological factors. Immunoblot analysis identified Cox-2 in all of pancreatic cancer tissues and 60% of cell lines.
Conclusion
The biological role of cyclooxygenase-2 (Cox-2) in carcinoma cells should be investigated with reference to the cancer progression of the pancreas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Thun MJ, Namboodiri MM, Health CWJ. Aspirin use and reduced risk of fatal colon cancer.N Engl J Med 1991; 325: 1593–1596.
Thun MJ. NAID use and decreased risk of gastrointestinal cancers.Gastroenterol Clin North Am 1996; 25: 333–348.
DuBois RN, Giardiello FM, Smalley WE. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.Gastroenterol Clin North Am 1996; 25: 773–791.
Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis.Gastroenterology 1991; 101: 635–639.
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano RNP, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.N Engl J Med 1991; 328: 1313–1316.
Spagnesi MT, Tonelli F, Dolara P, Caderni G, Valanzano R, Anastasi A, et al. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.Gastroenterology 1994; 106: 362–366.
Williams CW, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms?Am J Physiol 1996; 270: G393-G400.
Coffey RJ, Hawkey CJ, Damstrup L, Graves DR, Daniel VC, Dempsey PJ, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.Proc Natl Acad Sci USA 1997; 94: 657–662.
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.Gastroenterology 1994; 107: 1183–1188.
Kargman SL, O'Neill GP, Vickers PJ, Evance JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer.Cancer Res 1995; 55: 2556–2559.
Ristmäski A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma.Cancer Res 1997; 57: 1276–1280.
DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors.Gastroenterology 1996; 110: 1259–1262.
Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.Cancer Res 1987; 47: 5340–5346.
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).Cell 1996; 87: 803–809.
Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.Proc Natl Acad Sci USA 1997; 94: 3336–3340.
Liu XH, Rose DP. Differential expression and regulation of cyclooxygenase-1 and-2 in two human breast cancer cell lines.Cancer Res 1996; 56: 5125–5127.
Creminon C, Habib A, Maclouf J, Pradelles P, Grassi J, Frobert Y. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays.Biochim Biophys Acta 1995; 1254: 341–348.
Fujimoto K, Hosotani R, Wada M, Lee JU, Koshiba T, Miyamoto Y, et al. Expression of two angiogenic factors vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer and its relation to angiogenesis.Euro J Can, 1998; 34: 1439–1447.
Koshiba T, Hosotani R, Wada M, Lee JU, Fujimoto K, Miyamoto Y, et al. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic cancer.Cancer 1998; 94: 3336–3340.
Ohhashi K, Murakami Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I. Four cases of mucous secreting pancreatic cancer.Prog Dig Endosc 1982; 20: 348–351.
Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, et al. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation withN-nitrosobis(2-oxopropyl)amine.Carcinogenesis 1990; 11: 393–395.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koshiba, T., Hosotani, R., Miyamoto, Y. et al. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Int J Gastrointest Canc 26, 69–76 (1999). https://doi.org/10.1007/BF02781733
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02781733